Products found to contain undeclared medicines
|
| |
| Australia: Safety advisory: Ranzhishou slimming capsules were found to contain undeclared sibutramine and phenolphthalein |
| |
The Therapeutic Goods Administration (TGA) has tested product labelled Ranzhishou slimming capsules and found that the capsules contain the undeclared substance sibutramine and phenolphthalein. Ranzhishou slimming capsules pose a serious risk to health and should not be taken.
Consumers are advised that sibutramine and phenolphthalein are both prescription-only substances in Australia. Sibutramine was withdrawn from world markets in 2010 due to increased risk of cardiac events and stroke, and phenolphthalein was withdrawn from sale on many markets in the late 1990’s due to concerns over its carcinogenicity with long term use. TGA investigations have shown that a number of people in Australia may have bought the product online.
Consumers are advised to stop taking the product and consult their health care practitioner if they have any concerns arising from the use of the product.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/alert/ranzhishou-slimming-capsules
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Monday, April 11, 2016
Issued at HKT 13:00
|
| |
